Truvada Plus Raltegravir for Nonoccupational Post-exposure Prophylaxis (nPEP)
This study is ongoing, but not recruiting participants.
The University of Texas Health Science Center, Houston
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Karen Vigil, The University of Texas Health Science Center, Houston
First received: September 30, 2010
Last updated: July 18, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||August 2014|
|Estimated Primary Completion Date:||December 2013 (Final data collection date for primary outcome measure)|